|
시장보고서
상품코드
1416735
심실보조장치(VAD) 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)Ventricular Assist Device Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
Lucintel
심실보조장치(VAD) 동향과 전망
세계 심실보조장치(VAD) 시장은 2024-2030년간 연평균 10.5%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2030년 약 32억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 심부전 유병률 증가와 심혈관 질환 환자 수 증가입니다. 세계 심실보조장치(VAD) 시장의 미래는 이식, 목적지 치료, 회복, 치료 후보에 대한 교량 역할의 응용 분야에서 기회가 있어 유망해 보입니다.
심실보조장치(VAD) 시장별 인사이트
Lucintel은 심장의 펌프 기능을 개선하기 위해 심장 질환을 앓고 있는 환자들 사이에서 이식형 심실보조장치(VAD)의 사용이 증가함에 따라 예측 기간 동안 더 높은 성장세를 보일 것으로 예상했습니다.
이 시장 중 목적지 치료는 가장 높은 성장세를 보일 것으로 예상됩니다.
북미는 강력한 의료 시스템과 지역 내 주요 기업의 존재로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
자주 묻는 질문
Q1. 시장 규모 :
A1. 세계 심실보조장치(VAD) 시장은 2030년까지 약 32억 달러에 달할 것으로 예상됩니다.
Q2. 시장 성장 예측은 다음과 같습니다.
A2. 세계 심실보조장치(VAD) 시장은 2024-2030년 동안 10.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 다음과 같습니다.
A3.이 시장의 주요 촉진요인은 심부전 유병률 증가와 심혈관 질환 환자 수 증가입니다.
Q4. 시장의 주요 부문은 다음과 같습니다.
A4. 심실보조장치(VAD) 시장의 미래는 이식, 목적지 치료, 회복, 치료 후보에 대한 교량 역할에 대한 기회가 있어 유망해 보입니다.
Q5. 시장 주요 기업은 다음과 같습니다.
A5. 주요 심실보조장치(VAD) 기업은 다음과 같습니다.
- Abbott Laboratories
- Corewave
- Bivacor
- Carmat
- Jarvik Heart
Q6. 향후 가장 큰 시장 부문은 다음과 같습니다.
A6.Lucintel은 이식형 심실보조장치(VAD)은 심장 펌프 기능을 개선하기 위해 심장 질환을 앓고 있는 환자들 사이에서 사용이 증가함에 따라 예측 기간 동안 더 높은 성장을 보일 것으로 예상하고 있습니다.
Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디입니까?
A7. 북미는 강력한 의료 시스템의 존재와 지역 내 주요 기업의 존재로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
Q8. 보고서 사용자 정의가 가능합니까?
A8.네. Lucintel은 추가 비용 없이 10%의 커스터마이징을 명시하고 있습니다.
목차
제1장 주요 요약
제2장 세계의 심실보조장치(VAD) 시장 : 시장 역학
- 서론, 배경, 분류
- 공급망
- 업계 촉진요인과 과제
제3장 시장 동향과 예측 분석(2018-2030년)
- 거시경제 동향(2018-2023년)과 예측(2024-2030년)
- 세계의 심실보조장치(VAD) 시장 동향(2018-2023년)과 예측(2024-2030년)
- 설계별 세계의 심실보조장치(VAD) 시장
- 경피적 심실보조장치
- 삽입형 심실보조장치(VAD)
- 제품별 세계의 심실보조장치(VAD) 시장
- 좌심실 보조장치(LVAD)
- 우심실 보조장치(RVAD)
- 양심실 보조장치(BIVAD)
- 용도별 세계의 심실보조장치(VAD) 시장
- Bridge-to-Transplant
- Destination Therapy
- Bridge-to-Recovery
- Bridge to Candidacy Therapy
- 최종 용도별 세계의 심실보조장치(VAD) 시장
- 외래수술센터(ASC)
- 병원
- 기타
제4장 지역별 시장 동향과 예측 분석(2018-2030년)
- 지역별 세계의 심실보조장치(VAD) 시장
- 북미의 심실보조장치(VAD) 시장
- 유럽의 심실보조장치(VAD) 시장
- 아시아태평양의 심실보조장치(VAD) 시장
- 기타 지역의 심실보조장치(VAD) 시장
제5장 경쟁 분석
- 제품 포트폴리오 분석
- 운영상 통합
- Porter의 Five Forces 분석
제6장 성장 기회와 전략적 분석
- 성장 기회 분석
- 설계별 세계의 심실보조장치(VAD) 시장 성장 기회
- 제품별 세계의 심실보조장치(VAD) 시장 성장 기회
- 용도별 세계의 심실보조장치(VAD) 시장 성장 기회
- 최종 용도별 세계의 심실보조장치(VAD) 시장 성장 기회
- 지역별 세계의 심실보조장치(VAD) 시장 성장 기회
- 세계 심실보조장치(VAD) 시장의 새로운 동향
- 전략적 분석
- 신제품 개발
- 세계의 심실보조장치(VAD) 시장 생산능력 확대
- 세계 심실보조장치(VAD) 시장에서의 인수합병(M&A) 및 합작투자(JV)
- 인증 및 라이선싱
제7장 유력 기업 개요
- Abbott Laboratories
- Corewave
- Bivacor
- Carmat
- Jarvik Heart
Ventricular Assist Device Trends and Forecast
The future of the global ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications. The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.
A more than 150-page report is developed to help in your business decisions.
Ventricular Assist Device by Segment
The study includes a forecast for the global ventricular assist device by design, product, application, end use, and region.
Ventricular Assist Device Market by Design [Shipment Analysis by Value from 2018 to 2030]:
- Transcutaneous Ventricular Assist Devices
- Implantable Ventricular Assist Devices
Ventricular Assist Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:
- Left Ventricular Assist Devices (LVADs)
- Right Ventricular Assist Devices (RVADs)
- Biventricular Assist Devices (BIVADs)
Ventricular Assist Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:
- Bridge-to-Transplant
- Destination Therapy
- Bridge-to-Recovery
- Bridge to Candidacy Therapy
Ventricular Assist Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Ambulatory Surgery Centers
- Hospital
- Others
Ventricular Assist Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Ventricular Assist Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ventricular assist device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ventricular assist device companies profiled in this report include-
- Abbott Laboratories
- Corewave
- Bivacor
- Carmat
- Jarvik Heart
Ventricular Assist Device Market Insights
Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.
Within this market, destination therapy is expected to witness the highest growth.
North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.
Features of the Global Ventricular Assist Device Market
Market Size Estimates: Ventricular assist device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Ventricular assist device market size by various segments, such as by design, product, application, end use, and region in terms of value ($B).
Regional Analysis: Ventricular assist device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different designs, products, applications, end uses, and regions for the ventricular assist device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ventricular assist device market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the ventricular assist device market size?
Answer: The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030.
Q2. What is the growth forecast for ventricular assist device market?
Answer: The global ventricular assist device market is expected to grow with a CAGR of 10.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the ventricular assist device market?
Answer: The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.
Q4. What are the major segments for ventricular assist device market?
Answer: The future of the ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications.
Q5. Who are the key ventricular assist device market companies?
Answer: Some of the key ventricular assist device companies are as follows:
- Abbott Laboratories
- Corewave
- Bivacor
- Carmat
- Jarvik Heart
Q6. Which ventricular assist device market segment will be the largest in future?
Answer: Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.
Q7. In ventricular assist device market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the ventricular assist device market by design (transcutaneous ventricular assist devices and implantable ventricular assist devices), product (left ventricular assist devices, right ventricular assist devices, and biventricular assist devices), application (bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy), end use (ambulatory surgery centers, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Ventricular Assist Device Market : Market Dynamics
- 2.1: Introduction, Background, and Classifications
- 2.2: Supply Chain
- 2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
- 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
- 3.2. Global Ventricular Assist Device Market Trends (2018-2023) and Forecast (2024-2030)
- 3.3: Global Ventricular Assist Device Market by Design
- 3.3.1: Transcutaneous Ventricular Assist Devices
- 3.3.2: Implantable Ventricular Assist Devices
- 3.4: Global Ventricular Assist Device Market by Product
- 3.4.1: Left Ventricular Assist Devices (LVADs)
- 3.4.2: Right Ventricular Assist Devices (RVADs)
- 3.4.3: Biventricular Assist Devices (BIVADs)
- 3.5: Global Ventricular Assist Device Market by Application
- 3.5.1: Bridge-to-Transplant
- 3.5.2: Destination Therapy
- 3.5.3: Bridge-to-Recovery
- 3.5.4: Bridge to Candidacy Therapy
- 3.6: Global Ventricular Assist Device Market by End Use
- 3.6.1: Ambulatory Surgery Centers
- 3.6.2: Hospital
- 3.6.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
- 4.1: Global Ventricular Assist Device Market by Region
- 4.2: North American Ventricular Assist Device Market
- 4.2.2: North American Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
- 4.3: European Ventricular Assist Device Market
- 4.3.1: European Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
- 4.3.2: European Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
- 4.4: APAC Ventricular Assist Device Market
- 4.4.1: APAC Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
- 4.4.2: APAC Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
- 4.5: ROW Ventricular Assist Device Market
- 4.5.1: ROW Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
- 4.5.2: ROW Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
5. Competitor Analysis
- 5.1: Product Portfolio Analysis
- 5.2: Operational Integration
- 5.3: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
- 6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Ventricular Assist Device Market by Design
- 6.1.2: Growth Opportunities for the Global Ventricular Assist Device Market by Product
- 6.1.3: Growth Opportunities for the Global Ventricular Assist Device Market by Application
- 6.1.4: Growth Opportunities for the Global Ventricular Assist Device Market by End Use
- 6.1.5: Growth Opportunities for the Global Ventricular Assist Device Market by Region
- 6.2: Emerging Trends in the Global Ventricular Assist Device Market
- 6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Ventricular Assist Device Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ventricular Assist Device Market
- 6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
- 7.1: Abbott Laboratories
- 7.2: Corewave
- 7.3: Bivacor
- 7.4: Carmat
- 7.5: Jarvik Heart
